Research Output 1978 2020

Filter
Meeting Abstract
2019

A Multicountry Trend Analysis of Diabetes Incidence

Magliano, D. J., Islam, R. M., Chen, L., Carstensen, B., Pavkov, M. E., Gregg, E. W., Tabesh, M., Koye, D., Harding, J., Shaw, J. E. & Globodiab Writing Group, Jun 2019, In : Diabetes. 68, Supplement 1, 1 p., 1615-P.

Research output: Contribution to journalMeeting AbstractOtherpeer-review

A Systematic Review of Trends in All-Cause Mortality among People with Diabetes

Chen, L., Islam, R. M., Wang, J., Hird, T. R., Pavkov, M. E., Gregg, E. W., Tabesh, M., Koye, D., Harding, J. L., Sacre, J. W., Barr, E. L. M., Magliano, D. & Shaw, J. E., Jun 2019, In : Diabetes. 68, Supplement 1, 1 p., 1659-P.

Research output: Contribution to journalMeeting AbstractOtherpeer-review

Impact of Urine Output as a Criterion for Acute Kidney Injury after Cardiopulmonary Bypass Surgery

Kawakami, D., Fujii, T., Uchino, S., Doi, K., Korenaga, A., Nakamori, Y. & Suga, M., 2019, In : Critical Care Medicine. 47, 1, p. 699-699 1 p.

Research output: Contribution to journalMeeting AbstractOtherpeer-review

Testosterone: the known knowns, the known unknowns and the unknown unknowns

Davis, S., Skiba, M. A., Robinson, P. J., Islam, R. M. & Bell, R. J., Jun 2019, In : Maturitas. 124, p. 116-116 1 p., INV18.

Research output: Contribution to journalMeeting AbstractOtherpeer-review

Time Trends in Diabetes Incidence and Obesity Prevalence in Six Countries

Hird, T. R., Chen, L., Islam, R. M., Pavkov, M. E., Gregg, E. W., Tabesh, M., Koye, D., Barr, E. L., Shaw, J. E., Magliano, D. & Globodiab Writing Group, Jun 2019, In : Diabetes. 68, Supplement 1, 1 p., 1593-P.

Research output: Contribution to journalMeeting AbstractOtherpeer-review

Traditional Sex Steroids and Ketoandrogen Levels by Menstrual Cycle Stage, Age and Body Mass Index in Women Aged 18-39 Years

Skiba, M. A., Bell, R. J., Handelsman, D. J., Desai, R., Robinson, P., Islam, R. M. & Davis, S., 30 Apr 2019, In : Journal of the Endocrine Society. 3, Supplement 1, 1 p., SAT-LB001.

Research output: Contribution to journalMeeting AbstractOtherpeer-review

Open Access
2018

Combination of Nilotinib and Pegylated Interferon Alfa-2b Results in High Molecular Response Rates in Chronic Phase CML: Interim Results of the ALLG CML 11 Pinnacle Study: Blood 2018 132:459

Yeung, D. T., Grigg, A. P., Shanmuganathan, N., Cunningham, I., Shortt, J., Rowlings, P., Reynolds, J., Cushion, R., Harrup, R., Ross, D. M., Kipp, D., Mills, A. K., Arthur, C., Schwarer, A. P., Jackson, K., Viiala, N., Weinkove, R., Yong, A., White, D. L., Branford, S. & 1 othersHughes, T. P., Nov 2018, In : Blood. 132, Suppl 1, p. 459-459 1 p.

Research output: Contribution to journalMeeting AbstractOtherpeer-review

Phase 2 Trial of the Combination of Ixazomib, Thalidomide and Dexamethasone (ITD) in Relapsed/Refractory Myeloma: Planned Preliminary Analysis

Bergin, K., Yuen, F., Wallington-Beddoe, C. T., Kalff, A., Sirdesai, S., Reynolds, J. & Spencer, A., 29 Nov 2018, In : Blood. 132, Suppl 1, 1 p., 3265.

Research output: Contribution to journalMeeting AbstractOtherpeer-review

Pomalidomide Alone or in Combination with Low Dose Dexamethasone As Maintenance Following Induction with Pomalidomide and Low Dose Dexamethasone in Relapsed and Refractory Myeloma (ALLG MM14)

Kalff, A., Kennedy, N., Reynolds, J., Quach, H., Ho, P. J., Horvath, N., Mollee, P., D'Rozario, J. M., Taylor, K., Estell, J. & Spencer, A., 21 Nov 2018, In : Blood. 132, Suppl 1, 1 p., 1986.

Research output: Contribution to journalMeeting AbstractOtherpeer-review

Preliminary Analysis of the Australasian Leukaemia and Lymphoma Group (ALLG) MM17 Trial: Response Adaptive Salvage Treatment with Carfilzomib-Thalidomide-Dexamethasone (KTd) for Newly Diagnosed Transplant Eligible Multiple Myeloma Patients Failing Front-Line Bortezomib-Based Induction Therapy: Blood 2018 132:3279

Spencer, A., Quach, H., Horvath, N., Kerridge, I. H., Yuen, F., Lee, E. S-H., Morris, E. S., Kalff, A., Bergin, K., Sirdesai, S., Gorniak, M., Mithraprabhu, S., Khong, T. & Reynolds, J., 29 Nov 2018, In : Blood. 132, Suppl 1, 1 p., 3279.

Research output: Contribution to journalMeeting AbstractOtherpeer-review

2017

Identification of Acetylation, Immune Cell Alterations and Gene Signature As Dynamic Biomarkers of Response to Panobinostat Treatment in Multiple Myeloma Patients

Mithraprabhu, S., Savvidou, I., Ramachandran, M., Kalff, A., Khong, T. T., Reed, K., Reynolds, J. & Spencer, A., 7 Dec 2017, In : Blood. 130, Suppl 1, 1 p., 1823.

Research output: Contribution to journalMeeting AbstractOtherpeer-review

Nilotinib in Combination with Pegylated Interferon Alfa-2b for CP-CML Leads to High Molecular Response Rates: Interim Results of the Pinnacle Study: Blood 2017 130:2898

Yeung, D., Grigg, A., Shanmuganathan, N., Cunningham, I., Shortt, J., Rowling, P., Reynolds, J., Cushion, R., Harrap, R., Ross, D. M., Kipp, D., Mills, A. K., Arthur, C. K., Schwarer, A. P., Jackson, K., Viiala, N., Weinkove, R., Yong, A. S. M., White, D. L., Branford, S. & 1 othersHughes, T. P., 7 Dec 2017, In : Blood. 130, Suppl 1, 2898.

Research output: Contribution to journalMeeting AbstractOtherpeer-review

Red Cell Alloimmunisation Is Associated with Development of Autoantibodies and Increased Red Cell Transfusion Requirements in Myelodysplastic Syndromes (MDS)

Singhal, D., Kutyna, M. M., Chhetri, R., Wee, A., Hague, S., Nath, L., Nath, S. V., Sinha, R., Wickham, N., Lewis, I. D., Ross, D. M., Bardy, P. G., To, L. B., Reynolds, J., Wood, E., Roxby, D. J. & Hiwase, D. K., 7 Dec 2017, In : Blood. 130, Suppl 1, p. 2411 1 p.

Research output: Contribution to journalMeeting AbstractOtherpeer-review

2016

Roar: A Phase Ib Trial of Oral Azacitidine (CC-486) in Combination with Lenalidomide and Dexamethasone (Rd) for Patients with Relapsed and/or Refractory (R/R) Multiple Myeloma Who Have Failed a Prior Lenalidomide-Containing Regimen

Kalff, A., Reed, K., Khong, T. T., Mithraprabhu, S., Ramachandran, M., Reynolds, J., Bergin, K., Thakurta, A., Wang, M., Spencer, A., Guzman, R., Cuoto, S. & Ren, Y., 2 Dec 2016, In : Blood. 128, 22, 1 p., 2121.

Research output: Contribution to journalMeeting AbstractOtherpeer-review

TOP2A a New Predictive Marker of Response to Carfilzomib in Multiple Myeloma

Reale, A., Khong, T., Mithraprabhu, S., Reynolds, J., Ramachandran, M., Savvidou, I., Bergin, K., Hocking, J. & Spencer, A., 2 Dec 2016, In : Blood. 128, 22, 1 p., 4461.

Research output: Contribution to journalMeeting AbstractOtherpeer-review

2015

Pre-exposure prophylaxis and risk compensation: evidence of decreased condom use at three-month follow-up among predominantly gay male participants in the VicPrEP study

De Wit, JBF., Murphy, DA., Lal, L., Audsley, J., Roth, N., Moore, R., Tee, BK., Read, T. & Wright, E. J., Sep 2015, In : Sexually Transmitted Infections. 91, Suppl 2, p. A68-A68 1 p.

Research output: Contribution to journalMeeting AbstractOtherpeer-review

2012

Visual function in early AMD

Dimitrov, P. N., Robman, L. D., Varsamidis, M., Aung, K. Z., Makeyeva, G., Busija, L., Vingrys, A. & Guymer, R., 2012, In : Clinical and Experimental Ophthalmology. 40, S1, p. 108-109 2 p.

Research output: Contribution to journalMeeting AbstractOtherpeer-review

2011

Community acquired bacteraemia in patients over the age of 60: A two year retrospective review

Barnes, S., Stockman, K., Kotsanas, D., Beauchamp, A. J., Korman, T. M. & Campbell, D. A., 2011, In : Internal Medicine Journal. 41, Suppl 1, p. 2-2 1 p., 02.

Research output: Contribution to journalMeeting AbstractOther

Open Access

Complete Molecular Response (CMR) Rate with Nilotinib in Patients (pts) with Chronic Myeloid Leukemia in Chronic Phase (CML-CP) without CMR After ≥ 2 Years on Imatinib: Preliminary Results From the Randomized ENESTcmr Trial of Nilotinib 400 Mg Twice Daily (BID) Vs Imatinib

Hughes, T. P., Lipton, J. H., Leber, B., Spector, N., Cervantes, F., Pasquini, R., Clementino, N., Schwarer, A. P., Mahon, F-X., Rea, D., Yeung, D. T., Kamel-Reid, S., Bendit, I., Reynolds, J., Williams, L., Szczudlo, T. & Branford, S., 18 Nov 2011, In : Blood. 118, 21, 606.

Research output: Contribution to journalMeeting AbstractOtherpeer-review

Non-Myeloablative transplantation of self-antigen expressing bone marrow prevents autoimmunie disease by peripheral tolerance mechanism

Chan, J., Hosseini, H., Oh, D., Chen, X., Chan, S., Yagita, H., Alderuccio, F. & Toh, B-H., 2011, In : Journal of Gene Medicine. 13, 7-8, p. 423 - 424 2 p.

Research output: Contribution to journalMeeting AbstractOtherpeer-review

2009

International Randomized Study of Interferon Vs STI571 (IRIS) 8-Year Follow up: Sustained Survival and Low Risk for Progression or Events in Patients with Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase (CML-CP) Treated with Imatinib.

Deininger, M., O'Brien, S. G., Guilhot, F., Goldman, J. M., Hochhaus, A., Hughes, T. P., Radich, J. P., Hatfield, A. K., Mone, M., Filian, J., Reynolds, J., Larson, R. A., Gathmann, I. & Druker, B. J., 20 Nov 2009, In : Blood. 114, 22, 1126.

Research output: Contribution to journalMeeting AbstractOtherpeer-review

2007

Lifting the weight off arthritis: The epidemiology of obesity and arthritis in Australia

Busija, L., Ackerman, I. N., Davidson, N., Buchbinder, R. & Osborne, R. H., 2007, In : Internal Medicine Journal. A43.

Research output: Contribution to journalMeeting AbstractOtherpeer-review